Post-marketing surveillance study

A post-marketing surveillance study (PMS study), also known as a Phase IV study, may be voluntary or imposed by the regulatory authorities. They are conducted after marketing authorisation is granted and the medicine is in general use. Post-marketing surveillance studies collect additional information about side-effects and safety, long-term risks and benefits, and/or how well the medicine works when it is used widely.

[mla_gallery meta_key="eupasset_name" meta_value="phases-clinical-development" columns="1" mla_caption="{+caption+}" link="file" size="full"]

» Glossary